These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21975525)

  • 21. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validity of irritability in Huntington's disease: A scoping review.
    Simpson J; Dale M; Theed R; Gunn S; Zarotti N; Eccles FJR
    Cortex; 2019 Nov; 120():353-374. PubMed ID: 31401402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.
    Alexopoulos GS; Katz IR; Reynolds CF; Carpenter D; Docherty JP;
    Postgrad Med; 2001 Oct; Spec No Pharmacotherapy():1-86. PubMed ID: 17205639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current therapeutic options for Huntington's disease: good clinical practice versus evidence-based approaches?
    Killoran A; Biglan KM
    Mov Disord; 2014 Sep; 29(11):1404-13. PubMed ID: 25164707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survey of the Huntington's Disease Patient and Caregiver Community Reveals Most Impactful Symptoms and Treatment Needs.
    Simpson JA; Lovecky D; Kogan J; Vetter LA; Yohrling GJ
    J Huntingtons Dis; 2016 Dec; 5(4):395-403. PubMed ID: 27983566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).
    van Duijn E; Craufurd D; Hubers AA; Giltay EJ; Bonelli R; Rickards H; Anderson KE; van Walsem MR; van der Mast RC; Orth M; Landwehrmeyer GB;
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1411-8. PubMed ID: 24828898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expert consensus guideline series. Treatment of behavioral emergencies 2005.
    Allen MH; Currier GW; Carpenter D; Ross RW; Docherty JP;
    J Psychiatr Pract; 2005 Nov; 11 Suppl 1():5-108; quiz 110-2. PubMed ID: 16319571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present.
    Persico AM; Ricciardello A; Lamberti M; Turriziani L; Cucinotta F; Brogna C; Vitiello B; Arango C
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110326. PubMed ID: 33857522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic treatment of noncognitive symptoms of dementia.
    Karlsson I
    Acta Neurol Scand Suppl; 1996; 165():101-4. PubMed ID: 8740995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidepressants plus benzodiazepines for adults with major depression.
    Ogawa Y; Takeshima N; Hayasaka Y; Tajika A; Watanabe N; Streiner D; Furukawa TA
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD001026. PubMed ID: 31158298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [How to treat and manage unsatisfactory response?].
    El-Hage W; Fakra E
    Encephale; 2016 Feb; 42(1 Suppl 1):1S39-47. PubMed ID: 26879256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excessive response to provocation rather than disinhibition mediates irritable behaviour in Huntington's disease.
    McLauchlan DJ; Linden DEJ; Rosser AE
    Front Neurosci; 2022; 16():993357. PubMed ID: 36643017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Huntington's Disease: Prevalence and Psychological Indicators of Pain.
    Underwood M; Bonas S; Dale M;
    Mov Disord Clin Pract; 2017; 4(2):198-204. PubMed ID: 30363479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International Study of Expert Judgement on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications: V. Treatment strategies in panic disorder, 1992-1997.
    Uhlenhuth EH; Balter MB; Ban TA; Yang K
    J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):27S-31S. PubMed ID: 9872710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventive drugs for Huntington's disease: A choice-based conjoint survey of patient preferences.
    Parrish MC; Hanson-Kahn A; Srinivasan V; Grimes KV
    J Clin Transl Sci; 2022; 6(1):e35. PubMed ID: 35433035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Considerations and Current Trends in the Management of the Geriatric Patient on a Consultation-Liaison Service.
    Glass OM; Hermida AP; Hershenberg R; Schwartz AC
    Curr Psychiatry Rep; 2020 Apr; 22(5):21. PubMed ID: 32285305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Vasopressin 1a Receptor Antagonist SRX246 Reduces Aggressive Behavior in Huntington's Disease.
    Maibach HT; Brownstein MJ; Hersch SM; Anderson KE; Itzkowitz DE; Damiano EM; Simon NG
    J Pers Med; 2022 Sep; 12(10):. PubMed ID: 36294700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of the psychiatric manifestations of Huntington's disease: a review of the literature.
    Leroi I; Michalon M
    Can J Psychiatry; 1998 Nov; 43(9):933-40. PubMed ID: 9825166
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.